Iridex (IRIX) Cash from Operations Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | -16.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -16.19% |
| Jan 3, 2026 | 147.58% |
| Sep 27, 2025 | 62.32% |
| Jun 28, 2025 | 70.06% |
| Mar 29, 2025 | 30.28% |
| Dec 28, 2024 | -26.46% |
| Sep 28, 2024 | -72.45% |
| Jun 29, 2024 | -16.21% |
| Mar 30, 2024 | 42.03% |
| Dec 30, 2023 | 38.43% |
| Sep 30, 2023 | 15.38% |
| Jul 1, 2023 | 55.60% |
| Apr 1, 2023 | 12.60% |
| Dec 31, 2022 | -114.14% |
| Apr 2, 2022 | -127.50% |
| Apr 3, 2021 | 914.18% |
| Sep 26, 2020 | 116.00% |
| Jun 27, 2020 | -45.60% |
| Mar 28, 2020 | 61.73% |
| Dec 28, 2019 | 90.78% |
| Sep 28, 2019 | 12.26% |
| Jun 29, 2019 | 41.36% |
| Mar 30, 2019 | -39.24% |
| Dec 29, 2018 | -120.30% |
| Sep 29, 2018 | -54.96% |
| Jun 30, 2018 | -366.44% |
| Mar 31, 2018 | -68.13% |
| Dec 30, 2017 | -174.63% |
| Sep 30, 2017 | -15.43% |
| Jul 1, 2017 | -32.95% |
| Apr 1, 2017 | -408.37% |
| Dec 31, 2016 | 89.58% |
| Apr 2, 2016 | -14.75% |
| Apr 4, 2015 | -4.34% |
| Sep 27, 2014 | 79.02% |
| Jun 28, 2014 | -27.43% |
| Mar 29, 2014 | 258.87% |
| Dec 28, 2013 | -244.96% |
| Sep 28, 2013 | 162.74% |
| Jun 29, 2013 | 289.40% |
| Mar 30, 2013 | 67.31% |
| Dec 29, 2012 | -73.33% |
| Sep 29, 2012 | -78.53% |
| Jun 30, 2012 | -349.34% |
| Mar 31, 2012 | -70.84% |